Skip to main content
OXFORD BIODYNAMICS PLC logo

OXFORD BIODYNAMICS PLC — Investor Relations & Filings

Ticker · OBD ISIN · GB00BD5H8572 LEI · 2138005Y1TK258O5U928 IL Professional, scientific and technical activities
Filings indexed 416 across all filing types
Latest filing 2023-12-21 Report Publication Anno…
Country GB United Kingdom
Listing IL OBD

About OXFORD BIODYNAMICS PLC

https://www.oxfordbiodynamics.com/

Oxford BioDynamics PLC is a global biotechnology company advancing personalized healthcare by developing and commercializing precision medicine tests. The company's proprietary EpiSwitch® platform utilizes 3D genomics and epigenetic biomarkers to create diagnostic solutions for life-changing diseases, with a focus on oncology. Its portfolio of clinical tests includes the EpiSwitch® PSE, a blood test that assesses the likelihood of prostate cancer with high accuracy to help reduce unnecessary biopsies, and the EpiSwitch® CiRT, a test designed to predict a patient's therapeutic response to Immune Checkpoint Inhibitor cancer therapies. The platform enables the translation of 3D genome regulation into clinical applications for precision medicine at scale.

Recent filings

Filing Released Lang Actions
Notice of Results
Report Publication Announcement Classification · 99% confidence The document is a formal announcement from Oxford BioDynamics Plc, identified by the 'RNS Number' and the header indicating it is provided by 'RNS, the news service of the London Stock Exchange'. The core content is a 'Notice of Results and Investor Webinar', stating when the company expects to announce its full-year results (for the year ended 30 September 2023) and subsequently host an investor presentation/webinar. This document is not the full financial report (10-K or IR) itself, but rather an announcement about the timing of the results release and a related event. This fits the definition of a Report Publication Announcement (RPA), which signals the upcoming release of a major report, or potentially a general Regulatory Filing (RNS). Since it specifically announces the publication of results and an associated event, RPA is the most precise fit, as it precedes the actual results filing.
2023-12-21 English
Director/PDMR Shareholding
Director's Dealing Classification · 100% confidence The document is an official announcement disseminated via RNS (RNS Number: 2451T) from Oxford BioDynamics PLC, dated November 13, 2023. The content explicitly details a transaction involving the sale of shares by a Non-Executive Director (Stephen Diggle) and provides the required regulatory notification tables under UK Market Abuse Regulation. This type of insider transaction reporting by directors/PDMRs directly corresponds to the definition of Director's Dealing (DIRS). Although it is distributed via RNS, the specific content mandates the DIRS classification over the general RNS fallback.
2023-11-13 English
OBD strengths commercial leadership
Board/Management Information Classification · 99% confidence The document is identified by the header 'RNS Number : 7049S' and contains a press release format announcing the appointment of a new Senior Vice President of Business and Corporate Development. This type of announcement, which is a general corporate update distributed via the Regulatory News Service (RNS), fits best under the 'Regulatory Filings' category as a general regulatory announcement, as it does not specifically match definitions for earnings (ER), management changes (MANG - though it is a management change, RNS is often used for these announcements), or director dealings (DIRS). Since it is a standard, non-financial results press release distributed via RNS, the most appropriate general classification is RNS.
2023-11-08 English
Holding(s) in Company
Major Shareholding Notification Classification · 99% confidence The document is explicitly labeled with "RNS Number : 6764S" and contains the standard header/footer information associated with RNS (Regulatory News Service) announcements from the London Stock Exchange. The content details a "TR-1: Standard form for notification of major holdings" concerning an acquisition or disposal of voting rights by ODEY ASSET MANAGEMENT LLP. This type of filing, which reports changes in significant share ownership thresholds, directly corresponds to the definition for Major Shareholding Notification (MRQ). Although RNS is a general category, MRQ is more specific and accurate for this content.
2023-11-07 English
Holding(s) in Company
Director's Dealing Classification · 98% confidence The document is clearly identified by the header 'RNS Number : 5445S' and contains structured data related to changes in share ownership, specifically detailing an acquisition or disposal of voting rights by a shareholder ('Arbuthnot Latham (Nominees) Limited') crossing a threshold. This format, including sections like '1a. Identity of the issuer', '2. Reason for the notification', and '7. Total positions of person(s) subject to the notification obligation', is characteristic of a Major Shareholding Notification (often filed under DTR 5 rules in the UK). The definition for Major Shareholding Notification is 'MRQ: Notification of changes in significant share ownership levels (crossing thresholds)'. Although the document originates from RNS (Regulatory Filings), the specific content points directly to MRQ.
2023-11-06 English
Director/PDMR Shareholding
Director's Dealing Classification · 100% confidence The document is an official notification disseminated via RNS (RNS Number: 3466S) from Oxford BioDynamics PLC, dated November 3, 2023. The content explicitly details 'PDMR Dealing' (Persons Discharging Managerial Responsibilities Dealing), specifically reporting share transfers and transactions by the Non-Executive Chairman, Matthew Wakefield. This type of insider transaction reporting, especially concerning directors' personal share dealings, directly corresponds to the definition of Director's Dealing (DIRS). Although it is distributed via RNS, the specific subject matter is highly indicative of DIRS rather than a general regulatory filing (RNS) or a remuneration report (DEF 14A).
2023-11-03 English

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.